Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Double uterus, hemivagina and renal agenesis is a rare congenital urogenital anomaly characterized by the presence of double uterus (didelphys, bicornuate or septum-complete or partial), unilateral cervico-vaginal obstruction (obstructed hemivagina-communicant, not communicant or septate and unilateral cervical atresia) and ipsilateral renal anomalies (renal agenesis and/or other urinary tract anomalies). Patients are usually diagnosed at puberty after menarche due to recurrent severe dysmenorrhea, chronic pelvic pain, excessive foul smelling mucopurulent discharge, spotting and intermenstrual bleeding (depending on the existence of uterine or vaginal communications). fever, dyspareunia, and a palpable abdominal, pelvic or vaginal mass (mucocolpos or pyocolpos) may also be present.
Biomarker and diagnostic research for double uterus-hemivagina-renal agenesis syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for double uterus-hemivagina-renal agenesis syndrome.
209 publications have been identified in PubMed for double uterus-hemivagina-renal agenesis syndrome. Kisho has analyzed 94 by research type. Research spans Case Report / Case Series (26%), Basic Science / Preclinical (21%), and Clinical Trial Publication (20%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 24 | 26% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 9:49 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research |
20 |
21% |
Clinical study results | 19 | 20% |
Research summaries | 18 | 19% |
Disease patterns and progression | 8 | 9% |
Testing and diagnosis research | 3 | 3% |
New treatment approaches | 2 | 2% |
Xie YQ (2026). [PMID: 41412556](https://pubmed.ncbi.nlm.nih.gov/41412556/). *Gene*. [Case Report / Case Series]
Zingkou E (2026). [PMID: 41511866](https://pubmed.ncbi.nlm.nih.gov/41511866/). *J Pathol*. [Review / Meta-Analysis]
Zafirovska P (2026). [PMID: 41863107](https://pubmed.ncbi.nlm.nih.gov/41863107/). *Pril (Makedon Akad Nauk Umet Odd Med Nauki)*. [Case Report / Case Series]
Palaparthi S (2026). [PMID: 42091310](https://pubmed.ncbi.nlm.nih.gov/42091310/). *Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu*. [Review / Meta-Analysis]
Ishida C (2026). [PMID: 32809547](https://pubmed.ncbi.nlm.nih.gov/32809547/). *Unknown Journal*. [Basic Science / Preclinical]
Jan A (2026). [PMID: 42272086](https://pubmed.ncbi.nlm.nih.gov/42272086/). *J Paediatr Child Health*. [Review / Meta-Analysis]
Mashhadi F (2026). [PMID: 41618368](https://pubmed.ncbi.nlm.nih.gov/41618368/). *J Ovarian Res*. [Clinical Trial Publication]
Salois MN (2026). [PMID: 41795154](https://pubmed.ncbi.nlm.nih.gov/41795154/). *Exp Dermatol*. [Basic Science / Preclinical]
Rajiah PS (2026). [PMID: 41886301](https://pubmed.ncbi.nlm.nih.gov/41886301/). *Radiographics*. [Review / Meta-Analysis]
Tibarewal P (2026). [PMID: 41215730](https://pubmed.ncbi.nlm.nih.gov/41215730/). *Dis Model Mech*. [Epidemiology / Natural History]